Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Unspecified Adult Solid Tumor, Protocol Specific 5 Carcinoma, Intraductal, Noninfiltrating 3 Prostatic Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurofibrosarcoma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Malignant mesenchymal tumor 1 Liposarcoma 1 Leiomyosarcoma 1 Hot Flashes 1 Histiocytoma, Malignant Fibrous 1 Hepatitis C 1 Hemangiosarcoma 1

Interventions

Cyclophosphamide 56 Etoposide 40 Filgrastim 37 Carboplatin 34 Vincristine 30 Doxorubicin 30 Melphalan 27 Topotecan 25 Isotretinoin 24 Peripheral Blood Stem Cell Transplantation 23 Granulocyte Colony-Stimulating Factor 22 Cisplatin 21 Irinotecan 20 sargramostim 18 Temozolomide 17 humanized 3F8 anti-GD2 monoclonal antibody 15 Radiotherapy 15 3-Iodobenzylguanidine 13 Granulocyte-Macrophage Colony-Stimulating Factor 11 Busulfan 11 dinutuximab 10 Interleukin-2 9 aldesleukin 8 Thiotepa 8 Ifosfamide 8 etoposide phosphate 7 Mesna 7 Vorinostat 6 Stem Cell Transplantation 6 Polymerase Chain Reaction 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuroblastoma × Chromatography, High Pressure Liquid × Clear all

NCT00646230 2026-04-14

IV Fenretinide

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡